Further, in our quest to identify the executor pathway for pancreatic cancer cell death, we found Caspase 8 to be significantly increased in cells expressing TLR2- and TRL9-specific intrabodies compared to the control cells (Figure 2C). The gene discussed is CASP8; the disease is pancreatic neoplasm.